Search clinical trials for: Radiopharmaceutical 68Ga-DOTATATE

Total 1373 results

Peking University Cancer Hospital & Institute
Peking University Health Science Center

Recruiting

68Ga-ICAM-1pep PET/CT in Cancer Patients

Cancer

China
Xiangya Hospital of Central South University

Completed

Clinical Translation of a Novel FAPI Dimer [68Ga]Ga-LNC1013

Gastrointestinal Cancer

China
Andrei Iagaru
General Electric

Completed

68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

Prostate Cancer

United States
Peking University

Not yet recruiting

Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrine Tumors

China
Novartis Pharmaceuticals

Recruiting

A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy.

Metastatic Castration-resistant Prostate Cancer (mCRPC)

France
British Columbia Cancer Agency

Recruiting

DOTATOC PET/CT for Imaging NET Patients

Pituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary Carcinoma

Canada
Hexin (Suzhou) Pharmaceutical Technology Co., Ltd
Wuhan Union Hospital, China

Completed

A Clinical Study of 68Ga-HX01 Injection for PET Imaging

Healthy | Malignancy

China
BAMF Health
Telix International Pty Ltd

Recruiting

Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

Metastatic Castration-resistant Prostate Cancer

United States
Weill Medical College of Cornell University

Active, not recruiting

Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC

Prostate Cancer

United States
University Hospital, Basel, Switzerland

Not yet recruiting

61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)

Neuroendocrine Tumors

Switzerland
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer

Prostate Cancer | Positron-Emission Tomography

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection

Prostate Neoplasm
Xijing Hospital

Completed

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

Lung Cancer | Lung Tuberculosis
University Health Network, Toronto

Recruiting

DOTATATE PETMRI AAA Study

Abdominal Aortic Aneurysm

Canada
Ipsen

Terminated

Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer

Breast Cancer

Austria
Wuhan Union Hospital, China

Recruiting

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

Malignant Neoplasm

China
Novartis Pharmaceuticals

Recruiting

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Spain, France
University of Cambridge
Lund University; GE Healthcare; Cambridge University Hospitals NHS Foundation... and other collaborators

Recruiting

PET Imaging of Inflammation and Lipid Lowering Study (PIILL)

Atherosclerosis | Carotid Artery Plaque | Hypercholesterolemia | Hypercholesterolemia, Familial

United Kingdom
Weill Medical College of Cornell University
Merck Sharp & Dohme LLC; Novartis; GI Research Foundation

Recruiting

Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer (iPRRT)

Merkel Cell Carcinoma

United States
Tine Gregersen, MD

Recruiting

Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients (DOBATOC)

Neuroendocrine Neoplasm

Denmark
UNC Lineberger Comprehensive Cancer Center

Active, not recruiting

PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study

Prostate Cancer

United States
Medical University of Warsaw

Completed

Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin

Glioma, Malignant | Glioma Glioblastoma Multiforme

Poland
Peking Union Medical College Hospital

Unknown

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Lymphatic Disorders

China
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI PET/MR for Atherosclerosis

Atherosclerosis

China
Peking Union Medical College Hospital

Recruiting

Characterizing IgG4-RD With 68Ga-FAPI PET/CT

IgG4-related Disease

China
Rigshospitalet, Denmark

Enrolling by invitation

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma Metastatic | GEP-NET

Denmark
Vastra Gotaland Region
Advanced Accelerator Applications

Active, not recruiting

177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours (LuPARP)

Thymoma | Neuroendocrine Tumors | Mesothelioma | Clinical Trial, Phase I

Sweden
The First Affiliated Hospital of Xiamen University

Recruiting

Characterizing Myositis With 68Ga-FAPI PET/CT

Myositis | Idiopathic Inflammatory Myopathies

China
Peking Union Medical College Hospital

Recruiting

FAPI-PET/CT in Psoriatic Arthritis

Psoriatic Arthritis

China
Peking Union Medical College Hospital

Recruiting

Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CT

Arthritis

China
Medical University Innsbruck
Novartis

Completed

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Neuroendocrine Tumors

Austria
Peking Union Medical College Hospital

Unknown

Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT

Inflammatory Bowel Disease

China
Dana Mathews

No longer available

Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer

Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic

United States
Institut Cancerologie de l'Ouest

Completed

Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer (PSMA REBIOLOC)

Prostate Cancer Recurrent

France
Rigshospitalet, Denmark

Recruiting

Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis (CuDOSIS)

Cardiac Sarcoidosis

Denmark
Peking Union Medical College Hospital

Unknown

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Neuroendocrine Tumors

China
Emory University
National Cancer Institute (NCI); National Institutes of Health (NIH); Telix Pharmaceuticals...

Active, not recruiting

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Prostate Adenocarcinoma

United States
Peking Union Medical College Hospital

Unknown

Characterizing SAPHO With 68Ga-FAPI PET/CT

SAPHO Syndrome

China
Novartis Pharmaceuticals
Alliance Foundation Trials, LLC.; RTOG Foundation, Inc.

Active, not recruiting

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC (PSMAddition)

Prostatic Neoplasms

United States, China, Canada, Spain, United Kingdom, Belgium, Japan, Taiwan, Germany, Singapore, Austria, Netherlands, Korea, Republic of, France, Switzerland, Denmark, Sweden, Poland, Czechia
Weill Medical College of Cornell University

Terminated

177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC

Prostate Cancer

United States
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Clear Cell Renal Cell Carcinoma

China
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Recruiting

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
UNC Lineberger Comprehensive Cancer Center

Withdrawn

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Prostate Cancer

United States
Dana Mathews

Withdrawn

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Prostate Cancer | Prostate Cancer Metastatic | Prostate Cancer Metastatic to Bone

United States
Jules Bordet Institute

Withdrawn

Randomized Phase III of PRRT Versus Interferon (CASTOR)

Gastro-intestinal Neuroendocrine Tumors

Belgium
Peking University First Hospital

Recruiting

68Ga-P3 PET/CT Imaging in Prostate

Neoplasms

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Clear Cell Renal Cell Carcinoma

China
Wuhan Union Hospital, China

Recruiting

A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer

Prostate Cancer | PET/MR | PET/CT

China
University of Michigan

Completed

Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer Metastatic

United States

Search clinical trials for: Radiopharmaceutical 68Ga-DOTATATE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations